Status Update
Logotype for Swiss Re AG

Swiss Re (SREN) Status Update summary

Event summary combining transcript, slides, and related documents.

Logotype for Swiss Re AG

Status Update summary

8 Jul, 2026

Strategic priorities and transformation

  • Addressed recurring earnings drags by cleaning underperforming portfolios, increasing U.S. casualty reserves, and reinforcing technical underwriting, data-driven decision-making, and talent initiatives.

  • Implemented a four-phase strategy, including immediate actions like iptiQ withdrawal, comprehensive reserve review, and a midterm ambition to set a new strategic North Star.

  • Focused on cost efficiency, targeting $300 million in operating cost savings by 2027, with $100 million realized by 2025.

  • Prioritized capital strength, maintaining a robust SST ratio and aiming for a 7%+ annual dividend per share increase over the next three years.

  • Maintained strong capitalisation and financial flexibility, with a focus on superior capital management.

Financial guidance and targets

  • Set a 2025 net income target of more than $4.4 billion, up from the previous $3.6 billion for 2024, reflecting a 22% increase.

  • Improved combined ratio targets for 2025: P&C Reinsurance to 85 or better, Corporate Solutions to better than 91.

  • Life & Health earnings target raised to $1.6 billion for 2025, with CSM release guidance adjusted to 8%.

  • Long-term return on equity aspiration remains above 14%.

  • No additional capital return (e.g., share buybacks) planned in the near term, focusing on dividend growth and business investment.

Portfolio management and reserving actions

  • Reduced exposure to U.S. casualty and large corporate risks, with total reserves for U.S. liability increasing from $10 billion to $13 billion in nine months and $3.1 billion added in 9M 2024.

  • Adopted a prudent reserving approach, positioning at the 90th percentile of best estimate range and maintaining an uncertainty load, especially in P&C Re.

  • No net prior year reserve releases expected in 2025; uncertainty load for P&C Re to be about $500 million.

  • iptiQ EMEA P&C business sold to Allianz Direct, with other iptiQ portfolios in runoff or under review, reducing net loss to ~$50m by 2027.

  • Business mix shifting toward shorter-tail lines, benefiting combined ratio over time.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more